The $15M EIB tranche provides non-dilutive cash, but the massive 126% dilution from the concurrent equity offering is the dominant event. Monitor the July 9 shareholder meeting: approval of authorized capital renewal opens the door for further dilution. The insider accumulation by CEO Taub is a modest signal of confidence, but Cochlear's passive exit below 10% signals strategic disinterest.
Price Chart
Executive Summary
Nyxoah disclosed receipt of $15M (€13.8M) from the second tranche of its EIB loan facility, bringing total June 2026 capital raised to ~$110M including the prior dilutive equity offering. The filing also reported that insider Robert Taub crossed above the 10% threshold (now 14.45%), while Cochlear Limited passively fell below 10% (now 5.85%) due to the equity raise's dilution. A shareholder meeting on July 9, 2026 will vote on renewing authorized capital, enabling further equity issuance.
Key Facts
- Received $15M (€13.8M) from EIB loan second tranche; total June 2026 capital raised ~$110M including the dilutive equity offering.
- Insider Robert Taub increased voting rights to 14.45% (crossed 10% threshold).
- Cochlear Investments fell from 14.999% to 5.85% of voting rights due to passive dilution from the capital increase.
- Extraordinary shareholder meeting on July 9, 2026 to vote on renewing authorized capital, allowing board to issue additional shares up to the amount of current capital over 5 years.
- Previous 424B5 filings from June 4 and June 8 raised ~$88.5M net via 55.2M shares at $1.72/share, increasing share count by ~126%.
Financial Impact
$15M non-dilutive EIB tranche is credit-positive but the ~$88.5M dilutive equity raise just days earlier overwhelms the positive signal. Total capital raised ~$110M in June 2026.
Risk Factors
- Further dilution if authorized capital renewal is approved at July 9 meeting and the board issues additional shares.
- Cash runway extended but company still pre-revenue with accumulated deficit of €321.7M; commercial launch execution risk for Genio in the U.S.
- Inspire IPR petitions were denied (per earlier filing context), limiting competitive positioning.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001104659-26-076812 |
| Document: tm2618580d1_ex99-2.htm | 0001104659-26-076812 |
| Document: tm2618580d1_6k.htm | 0001104659-26-076812 |
| Document: tm2618580d1_ex99-1.htm | 0001104659-26-076812 |
| Document: 0001104659-26-076812-index-headers.html | 0001104659-26-076812 |
| Document: 0001104659-26-076812-index.html | 0001104659-26-076812 |
| Document: 0001104659-26-076812.txt | 0001104659-26-076812 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | 6-K | $0.8950 $0.8220 | ▲ +8.16% | ▲ +6.98% | $0.8560 (+4.36%) |
Oct 19, 2026 7d ago | Press Release | $0.9540 $0.9400 | ▲ +1.47% | ▲ +1.80% | $0.8560 (+10.27%) |
Sep 22, 2026 4w ago | 6-K | $1.33 $1.27 | ▼ −4.51% | ▼ −4.43% | $0.8560 (−35.64%) |
Jun 23, 2026 17w ago | 6-K | $1.62 $1.63 | ▼ −0.62% | ▼ −0.47% | $0.8560 (+47.16%) |
Jun 11, 2026 19w ago | 6-K | $1.39 $1.55 | ▼ −11.51% | ▼ −9.75% | $0.8560 (+38.42%) |
Jun 8, 2026 20w ago | 6-K | $1.34 $1.31 | ▲ +2.24% | ▲ +0.66% | $0.8560 (+36.12%) |
Jun 8, 2026 20w ago | 424B5 | $1.39 $1.34 | ▲ +3.60% | ▲ +3.30% | $0.8560 (+38.42%) |
Jun 5, 2026 20w ago | Press Release | $1.45 $1.39 | ▲ +4.14% | ▲ +4.36% | $0.8560 (+40.97%) |
Jun 4, 2026 20w ago | 424B5 | $1.45 $1.39 | ▲ +4.14% | ▲ +4.36% | $0.8560 (+40.97%) |
May 20, 2026 22w ago | Press Release | $2.87 $2.87 | · 0.00% | ▼ −0.45% | $0.8560 (−70.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers